Disclosures for "A Lipopolysaccharide Mouse Model Mirrors Neuroinflammatory Transcriptional Signatures of Human AD, and the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Attenuates Neuroinflammation in this Model")
-
Dr. Ludwig has nothing to disclose.
-
Dr. Rausch has nothing to disclose.
-
Dr. Secher has received personal compensation for serving as an employee of Novo Nordisk. An immediate family member of Dr. Secher has received personal compensation for serving as an employee of Novo Nordisk. Dr. Secher has stock in Novo Nordisk.
-
Dr. Bentsen has received personal compensation for serving as an employee of Novo Nordisk. An immediate family member of Dr. Bentsen has stock in Novo Nordisk.
-
Dr. Hansen has received personal compensation for serving as an employee of Neumirna Therapeutics. Dr. Hansen has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Bjerregaard has received personal compensation for serving as an employee of Novo Nordisk A/S.
-
Dr. Niss has nothing to disclose.
-
Kristoffer L Egerod has nothing to disclose.
-
Dr. Hansen has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Hansen has stock in Novo Nordisk A/S.
-
Dr. Dalgaard has received personal compensation for serving as an employee of Novo Nordisk.
-
Dr. Merkestein has received personal compensation for serving as an employee of Novo Nordisk A/S.
-
Dorte Holst has nothing to disclose.
-
Charles Pyke has nothing to disclose.
-
Mrs. Wichern has received personal compensation for serving as an employee of Gubra ApS.
-
Dr. Polex-Wolf has received personal compensation for serving as an employee of Novo Nordisk A/S.
-
Tune H Pers has nothing to disclose.
-
Lotte B Knudsen has nothing to disclose.